Literature DB >> 14725901

Interleukin-4 elicits apoptosis of developing mast cells via a Stat6-dependent mitochondrial pathway.

Daniel P Bailey1, Mohit Kashyap, Paria Mirmonsef, L Andrew Bouton, Jos Domen, Jingfang Zhu, Emmanuel N Dessypris, John J Ryan.   

Abstract

OBJECTIVE: The aim of this study was to assess the effects of interleukin-4 and signal transducer and activator of transcription (Stat)-6 on IL-3+SCF-induced mast cell development. PATIENTS AND METHODS: Unseparated mouse bone marrow cells were cultured in IL-3+SCF, giving rise to mast cells and monocytes/macrophages. The addition of IL-4, the use of Stat6-deficient bone marrow cells, and expression of a constitutively active Stat6 mutant were employed to assess the effects of IL-4 and Stat6 on cell viability, proliferation, and differentiation. Bax-deficient and bcl-2 transgenic bone marrow cells were used to assess the importance of the mitochondria in IL-4-mediated effects.
RESULTS: IL-4 elicited apoptosis and limited the cell cycle progression of developing bone marrow cells, without affecting cell differentiation. Apoptosis required that IL-4 be present during the first 8 days of the 21-day culture period. Cell death correlated with loss of mitochondrial membrane potential. Accordingly, IL-4-mediated apoptosis was inhibited by Bax deletion or bcl-2 overexpression. Lastly, Stat6 activation was both necessary and sufficient to inhibit cell survival.
CONCLUSION: IL-4 exerts potent apoptotic effects on developing mast cells and monocyte/macrophages through mitochondrial damage and Stat6 activation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14725901     DOI: 10.1016/j.exphem.2003.10.011

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  11 in total

Review 1.  Systemic mast cell activation disease: the role of molecular genetic alterations in pathogenesis, heritability and diagnostics.

Authors:  Britta Haenisch; Markus M Nöthen; Gerhard J Molderings
Journal:  Immunology       Date:  2012-11       Impact factor: 7.397

Review 2.  Role of Mast Cells in Regulation of T Cell Responses in Experimental and Clinical Settings.

Authors:  Daniel Elieh Ali Komi; Korneel Grauwet
Journal:  Clin Rev Allergy Immunol       Date:  2018-06       Impact factor: 8.667

Review 3.  Mast cell production and response to IL-4 and IL-13.

Authors:  Jamie J A McLeod; Bianca Baker; John J Ryan
Journal:  Cytokine       Date:  2015-06-15       Impact factor: 3.861

4.  Endogenous suppression of mast cell development and survival by IL-4 and IL-10.

Authors:  Kelly Speiran; Daniel P Bailey; Josephine Fernando; Matthew Macey; Brian Barnstein; Motunrayo Kolawole; Dana Curley; Stephanie S Watowich; Peter J Murray; Carole Oskeritzian; John J Ryan
Journal:  J Leukoc Biol       Date:  2009-02-19       Impact factor: 4.962

5.  Interleukin-4 induces senescence in human renal carcinoma cell lines through STAT6 and p38 MAPK.

Authors:  Hag Dong Kim; Su-Jin Yu; Hee Suk Kim; Yong-Jin Kim; Jeong Min Choe; Yun Gyu Park; Joon Kim; Jeongwon Sohn
Journal:  J Biol Chem       Date:  2013-08-09       Impact factor: 5.157

6.  Polyclonal IgE induces mast cell survival and cytokine production.

Authors:  Jun-ichi Kashiwakura; Yuko Kawakami; Keisuke Yuki; Dirk M Zajonc; Shunji Hasegawa; Yoshiaki Tomimori; Benjamin Caplan; Hirohisa Saito; Masutaka Furue; Hans C Oettgen; Yoshimichi Okayama; Toshiaki Kawakami
Journal:  Allergol Int       Date:  2009-06-25       Impact factor: 5.836

7.  Direct effects of IL-4 on mast cells drive their intestinal expansion and increase susceptibility to anaphylaxis in a murine model of food allergy.

Authors:  O T Burton; A R Darling; J S Zhou; M Noval-Rivas; T G Jones; M F Gurish; T A Chatila; H C Oettgen
Journal:  Mucosal Immunol       Date:  2012-11-14       Impact factor: 7.313

Review 8.  Wheezing and itching: The requirement for STAT proteins in allergic inflammation.

Authors:  Nicole L Glosson; Heather A Bruns; Mark H Kaplan
Journal:  JAKSTAT       Date:  2012-01-01

9.  Small interfering RNA against transcription factor STAT6 leads to increased cholesterol synthesis in lung cancer cell lines.

Authors:  Richa Dubey; Ravindresh Chhabra; Neeru Saini
Journal:  PLoS One       Date:  2011-12-05       Impact factor: 3.240

10.  The Fyn-STAT5 Pathway: A New Frontier in IgE- and IgG-Mediated Mast Cell Signaling.

Authors:  Nicholas A Pullen; Yves T Falanga; Johanna K Morales; John J Ryan
Journal:  Front Immunol       Date:  2012-05-11       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.